Xenetic Biosciences Income Statement (2011-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	0.35M	0.33M	0.39M	0.42M	0.41M	0.49M	0.61M	0.65M	0.61M	0.67M	0.51M	0.73M	0.61M	0.65M	0.59M	0.59M	1.03M	0.77M	0.81M	0.66M
Cost of Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)	0.78M	1.23M	1.10M	2.08M	0.40M	1.19M	0.60M	0.90M	1.02M	0.98M	0.94M	0.93M	0.37M	1.04M	0.88M	0.66M	0.76M	0.77M	0.66M	0.55M
Selling, General & Administrative (Quarter)	0.95M	0.98M	0.91M	1.03M	0.86M	0.86M	0.93M	0.95M	0.74M	0.95M	0.83M	1.13M	0.75M	0.71M	0.66M	0.66M	0.82M	0.62M	0.65M	1.08M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	1.73M	2.21M	2.01M	3.10M	1.26M	2.05M	1.52M	1.85M	1.76M	1.93M	1.78M	2.06M	1.11M	1.75M	1.54M	1.31M	1.57M	1.39M	1.31M	1.63M
Operating Income (Quarter)	-1.38M	-1.87M	-1.62M	-2.69M	-0.85M	-1.56M	-0.92M	-1.20M	-1.15M	-1.26M	-1.27M	-1.34M	-0.50M	-1.10M	-0.94M	-0.72M	-0.54M	-0.62M	-0.50M	-0.97M
EBIT (Quarter)	-1.38M	-1.87M	-1.62M	-2.69M	-0.85M	-1.56M	-0.92M	-1.20M	-1.15M	-1.26M	-1.27M	-1.34M	-0.50M	-1.10M	-0.94M	-0.72M	-0.54M	-0.62M	-0.50M	-0.97M
Non-operating items
Interest & Investment Income (Quarter)															0.04M				0.05M	0.04M
Other Non Operating Income (Quarter)	-0.00M	0.00M	199.00	-0.00M	-0.00M	986.00	0.00M	0.02M	-666.00	404.00	52.00	-21.00	0.00M	-0.01M	78.00	0.00M	0.00M	159.00	-21.00	-72.00
Non Operating Income (Quarter)	0.03M	0.03M	0.03M	0.01M	0.04M	0.08M	0.06M	0.15M	0.09M	0.08M	0.07M	0.06M	0.06M	0.04M	0.04M	0.04M	0.03M	0.04M	0.05M	0.04M
Net income details
EBT (Quarter)	-1.35M	-1.88M	-33.42M	-35.29M	-33.65M	-1.59M	-39.62M	-40.20M	-40.35M	-1.26M	-41.37M	-41.74M	-41.10M	-1.10M	-42.30M	-42.32M	-42.24M	-0.62M	-40.36M	-41.13M
Tax Provisions (Quarter)		-1.19M
Profit After Tax (Quarter)	-1.35M	-1.84M	-1.59M	-2.67M	-0.80M	-1.48M	-0.86M	-1.05M	-1.06M	-1.17M	-1.20M	-1.27M	-0.44M	-1.05M	-0.90M	-0.69M	-0.51M	-0.58M	-0.46M	-0.93M
Income from Continuing Operations (Quarter)	-1.35M	-1.88M	-33.42M	-35.29M	-33.65M	-1.59M	-39.62M	-40.20M	-40.35M	-1.26M	-41.37M	-41.74M	-41.10M	-1.10M	-42.30M	-42.32M	-42.24M	-0.62M	-40.36M	-41.13M
Consolidated Net Income (Quarter)	-1.35M	-1.88M	-33.42M	-35.29M	-33.65M	-1.59M	-39.62M	-40.20M	-40.35M	-1.26M	-41.37M	-41.74M	-41.10M	-1.10M	-42.30M	-42.32M	-42.24M	-0.62M	-40.36M	-41.13M
Income towards Parent Company (Quarter)	-1.35M	-1.88M	-33.42M	-35.29M	-33.65M	-1.59M	-39.62M	-40.20M	-40.35M	-1.26M	-41.37M	-41.74M	-41.10M	-1.10M	-42.30M	-42.32M	-42.24M	-0.62M	-40.36M	-41.13M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-1.35M	-1.88M	-33.42M	-35.29M	-33.65M	-1.59M	-39.62M	-40.20M	-40.35M	-1.26M	-41.37M	-41.74M	-41.10M	-1.10M	-42.30M	-42.32M	-42.24M	-0.62M	-40.36M	-41.13M
Additional items
EPS (Basic) (Quarter)	-1.33	-1.83	-24.87	-25.09	-23.50	-1.12	-26.12	-26.36	-26.33	-0.82	-26.85	-27.09	-26.66	-0.71	-27.43	-27.45	-27.39	-0.37	-17.61	-17.93
EPS (Diluted) (Quarter)	-1.33	-1.83	-24.87	-25.09	-23.50	-1.12	-26.12	-26.36	-26.33	-0.82	-26.85	-27.09	-26.66	-0.71	-27.43	-27.45	-27.39	-0.37	-17.61	-17.93
Shares Outstanding (Quarter)	1.02M	1.03M	1.34M	1.41M	1.43M	1.42M	1.52M	1.52M	1.53M	1.53M	1.54M	1.54M	1.54M	1.54M	1.54M	1.54M	1.54M	1.70M	2.29M	2.29M
Shares Outstanding (Diluted) (Quarter)	1.02M	1.03M	1.34M	1.41M	1.43M	1.42M	1.52M	1.52M	1.53M	1.53M	1.54M	1.54M	1.54M	1.54M	1.54M	1.54M	1.54M	1.70M	2.29M	2.29M
Shares Outstanding (Entity) (Quarter)	1.02M	1.03M	1.35M	1.43M	1.43M	1.52M	1.52M	1.52M	1.53M	1.80M	1.80M	1.80M	1.80M	1.80M	1.80M	1.80M	1.80M	1.70M	2.29M	2.35M
EBITDA (Quarter)	-1.38M	-1.87M	-1.62M	-2.69M	-0.85M	-1.56M	-0.92M	-1.20M	-1.15M	-1.26M	-1.27M	-1.34M	-0.50M	-1.10M	-0.94M	-0.72M	-0.54M	-0.62M	-0.50M	-0.97M
Interest Expenses (Quarter)	30.50M	0.01M	31.80M	32.60M	32.80M	0.03M	38.70M	39.00M	39.20M		40.10M	40.40M	40.60M		41.40M	41.60M	41.70M		39.90M	40.20M
Tax Rate (Quarter)		62.95%

Research Tools

Datasets

Plans

Developers

Xenetic Biosciences XBIO Income Statement (2011-2026)

Research Tools

Datasets

Plans

Developers

Xenetic Biosciences XBIO Income Statement (2011-2026)

Create an account

Sign In

Reset Password